Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Biodesix, Inc. < Previous 1 2 3 Next > Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022 July 19, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test June 07, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Research Agreement with Top US Cancer Center June 03, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference June 01, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the H.C. Wainwright Global Investment Conference May 17, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference May 12, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces First Quarter 2022 Results and Highlights May 11, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022 April 27, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan April 11, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer March 29, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022 February 28, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022 February 22, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited) February 14, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 09, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces the Launch of its GeneStrat NGS™ Test and the IQLung™ Testing Strategy with Unprecedented Time to Results January 18, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan January 04, 2022 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors December 08, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer November 18, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Third Quarter 2021 Results and Highlights November 15, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present Data Supporting Proteomic-Based Immunotherapy Diagnostic Tests and AI Explainability in Diagnostic Tests at Society for Immunotherapy of Cancer Annual Meeting November 12, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum November 11, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021 November 01, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting October 13, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer September 16, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference September 02, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American Pathologists August 25, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Second Quarter 2021 Results and Highlights August 10, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference August 02, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021 July 27, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer June 17, 2021 From Biodesix, Inc. Via Business Wire Tickers BDSX < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.